Ingelvac Prrs Mlv Vaccine

For vaccination of healthy, susceptible swine as an aid in the prevention of respiratory disease and an aid in the reduction of reproductive disease due to Porcine Reproductive and Respiratory Syndrome (PRRS) virus. The duration of immunity is at least 4 months or throughout the finishing period or gestation. For use only in healthy, susceptible animals in “PRRS virus positive herds” per label directions. PRRS positive herds means any herds that are PRRS serological positive, PRRS isolation positive, or PRRS clinical symptom positive. Many factors must be considered in determining a sound PRRS vaccination program for a particular farm. To be most effective, the vaccine must be administered properly to healthy animals maintained in a proper environment under good management.

Stressed or immunosuppressed pigs should not be vaccinated as the efficacy of the vaccine in these animals is unknown. Seldom does one vaccination under field condition produce lifetime protection for all individuals in a given herd. The level of individual animal and herd immunity required will vary with management practices, the degree of exposure to PRRS virus, and the level of susceptibility of each animal. The benefits and risks from vaccination will vary in part with the level of PRRS virus in the herd. The PRRS status of the herd or individual animals should be assessed by virus isolation, serological, or other diagnostic tests. Therefore, the vaccination program must be carefully planned and implemented following label and insert indications and precautions and the direction of a veterinarian.


Ingelvac PRRS® MLV, a leading modified-live PRRS vaccine, has been trusted for over 20 years to protect the swine industry against respiratory and reproductive symptoms of PRRSv. Ingelvac PRRS® MLV is a modified-live PRRS vaccine that is proven safe in pigs as well as gilts and sows at any stage of production in PRRS positive herds. It provides cross protection against heterologous challenge; (including Lelystad virus) and has shown to significantly reduce reproductive failure and respiratory disease due to PRRS virus. 

  • Trusted and field proven
  • Cost effective
  • Unique in its ability to be used in pigs (3 weeks or older), gilts, and sows at ANY stage of production
  • Available in three convenient sizes (10, 50, and 250 dose)

Porcine Reproductive and Respiratory Syndrome (PRRS) is a $664 million dollar problem.3 It has a devastating impact on pig performance, overall production and profits. Unlike many other swine diseases, the unique, single-strand RNA structure of the PRRS virus has made it a challenge for a generation of pork producers. For over 20 years, Boehringer Ingelheim Vetmedica Inc. has been helping the industry combat PRRS. With Ingelvac PRRS® vaccines, technical expertise, collaborative research and diagnostic advancements, we are working with veterinarians and producers to win the battles against this challenging disease.


  • Ingelvac PRRS® MLV utilizes the same intramuscular (IM) dose size (2 mL) for pigs, adult breeding-age or pregnant females.
  • Pigs, gilts and sows: Ingelvac PRRS® MLV is recommended for use in healthy susceptible swine in PRRS virus-positive herds according to label direction. Using aseptic technique, administer a single 2 mL dose intramuscularly (IM) for the respiratory and reproductive form of the disease. The duration of immunity is throughout the finishing or gestation period, or at least 4 months post vaccination.
  • The vaccine can be used at any stage of production. Revaccination of the whole herd can occur every 3-4 months or as directed by your veterinarian.

Uses of Ingelvac Prrs Mlv Vaccine:

  1. Whole herd/population PRRS control programs.
  2. Replacement gilt immunization and preparation.
  3. Reproductive maintenance vaccination in sows.

This swine vaccine can be used at any stage of production and revaccination of herd can occur every 3-4 months or as directed by your veterinarian.
Ingelvac PRRS MLV provides long-lasting immunity duration of at least 4 months.


For veterinary use only. For use only in swine as directed. Administer only to healthy pigs, gilts, or sows in PRRS virus positive herds, and only by intramuscular injection. Administer the complete 2 mL dose to each pig, gilt, or sow vaccinated. Efficacy and safety of the vaccine at other than the dose or route prescribed on the label is unknown and, therefore, not recommended and not USDA approved. Anaphylactoid reactions may occur. Specific herds may be particularly sensitive. Antidote: Epinephrine.

Prices of Ingelvac Prrs Mlv Vaccine

$38.85 – $254.99

Sharing is caring!

Leave a Comment

Your email address will not be published.

error: Content is protected !!